Procalcitonin (PCT) – ein Biomarker in der Sepsisdiagnostik

AWMF-Leitlinie Prävention, Diagnose, Therapie und Nachsorge der Sepsis. (PDF) Registernummer 079-001. https://www.awmf.org/leitlinien/aktuelle-leitlinien/ll-liste/deutsche-sepsis-gesellschaft-ev.html. Zugegriffen: Sep. 2019 Becker KL, Snider R, Nylen ES (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 36(3):941–952 Bundesärztekammer (2014) Neufassung der „Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen – Rili-BÄK“. Dtsch Arztebl 111:A1583–A1618 Chambliss AB, Hayden J, Colby JM (2019) Evaluation of procalcitonin immunoassay concordance near clinical decision points. Clin Chem Lab Med 57(9):1414–1421. https://doi.org/10.1515/cclm-2018-1362 Cohen J et al (2015) Sepsis: a roadmap for future research. Lancet Infect Dis 15:581–614. https://doi.org/10.1016/S1473-3099(15)70112-X Eynott PR et al (2002) Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. Eur J Pharmacol 452:123–133 Eynott PR et al (2003) Role of nitric oxide in chronic allergen-induced airway cell proliferation and inflammation. J Pharmacol Exp Ther 304:22–29 Groneberg DA et al (2004) Smads as intracellular mediators of airway inflammation. Exp Lung Res 30:223–250 Hangai S, Nannya Y, Kurokawa M (2015) Role of procalcitonin and C‑reactive protein for discrimination between tumor fever and infection in patients with hematological diseases. Leuk Lymphoma 56(4):910–914. https://doi.org/10.3109/10428194.2014.938329 https://www.aerzteblatt.de/archiv/192597. Zugegriffen: Sep. 2019 https://www.aerzteblatt.de/nachrichten/65831/Sepsis-3-Neue-Definition-stellt-Organversagen-in-den-Mittelpunkt. Zugegriffen: Sep. 2019 https://flexikon.doccheck.com/de/Procalcitonin. Zugegriffen: Sep. 2019 https://www.radiometer.de/de-de/diagnostics/sepsisdetection/procalcitonin---der-biomarker-der-wahl-f%C3%BCr-die-sepsisdiagnose. Zugegriffen: 09/2019 Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) § 23 Abs. 1 Stand 25.06.19. Lippi G (2019) Sepsis biomarkers: past, present and future. Clin Chem Lab Med 57(9):1281–1283. https://doi.org/10.1515/cclm-2018-1347 Meisner M (2010) Procalcitonin – Biochemie und klinische Diagnostik. UNI-MED, Bremen, S 8–16 Meisner M (2014) Update on Procalcitonin measurements. Ann Lab Med 34:263–273 Patout M, Salaün M, Brunel V, Bota S, Cauliez B, Thiberville L (2014) Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers. Clin Biochem 47(18):263–267. https://doi.org/10.1016/j.clinbiochem.2014.09.002 Schuetz P, Beishuizen A, Broyles M, Ferrer R, Gavazzi G, Gluck EH, González Del Castillo J, Jensen JU, Kanizsai PL, Kwa ALH, Krueger S, Luyt CE, Oppert M, Plebani M, Shlyapnikov SA, Toccafondi G, Townsend J, Welte T, Saeed K (2019) Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med 57(9):1308–1318. https://doi.org/10.1515/cclm-2018-1181 Seymour CW et al (2016) Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:762–774. https://doi.org/10.1001/jama.2016.0288 Singer M et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801–810. https://doi.org/10.1001/jama.2016.0287 Tang BM et al (2007) Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7:210 Thomas L (2012) Labor und Diagnose, 8. Aufl. TH-Books, Frankfurt/Main, S 1291 ff Verboon-Maciolek MA et al (2006) Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res 59:457